RBX2660 Shows Promise in Breaking the Cycle of Recurrent C diff RBX2660 Shows Promise in Breaking the Cycle of Recurrent C diff

Building on the success seen with fecal microbiota transplantation, this experimental treatment lowered the rates of recurrent C difficile infections.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news